Healthcare / Medical Care FacilitiesThailand
$10.60
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $235.1M · quality 82.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
59/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.2B
P/E
10.3x
↓EV/EBITDA
5.8x
↓ROE
14.0%
↑Gross Margin
25.0%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.1%
FCF CAGR
+6.2%
FCF margin
11.8%
FCF / Net income
0.96x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.51B · net income $309.5M · FCF $296.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.51B | $2.51B | $2.27B | $2.14B | $2.04B |
| Net Income | $309.5M | $309.5M | $252.2M | $259.5M | $293.1M |
| EBITDA | $493.5M | $493.5M | $411.2M | $417.1M | $449.8M |
| EPS | 1.03 | 1.03 | 0.84 | 0.95 | 0.98 |
| Gross Margin | 25.0% | 25.0% | 23.5% | 26.8% | 29.8% |
| Operating Margin | 15.5% | 15.5% | 13.9% | 15.6% | 18.6% |
| Net Margin | 12.3% | 12.3% | 11.1% | 12.1% | 14.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.03 | 0.34 |
| Current Ratio | 4.61 | 4.61 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $296.6M | $296.6M | $210.3M | $235.1M | $247.3M |
| Returns | |||||
| ROE | 14.0% | 14.0% | 12.3% | 13.2% | 30.0% |
| Valuation | |||||
| P/E | 10.29 | 10.29 | — | — | — |
| EV/EBITDA | 5.78 | 5.78 | — | — | — |
| P/B | 1.44 | 1.44 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 10.3% | 10.3% | 6.3% | 4.8% | — |
| EPS Growth | 22.6% | 22.6% | -11.6% | -2.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-3.0%
EPS terminal req.
$0.94
Spread vs growth
25.6%
5Y implied EPS CAGR
2.0%
EPS terminal req.
$1.14
Spread vs growth
20.6%
10Y implied EPS CAGR
5.9%
EPS terminal req.
$1.83
Spread vs growth
16.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
12.6x → 10.3x
EPS bridge
0.84 → 1.03
Residual
-4.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.